Protein transduction: An alternative to genetic intervention?

Gene Therapy

Volumn 8, Issue 1, 2001, Pages 1-4

  Ford, K G ^a   Souberbielle, B E ^a   Darling, D ^a   Farzaneh, F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antennapedia; Gene therapy; Protein transduction; TAT; VP22

Indexed keywords

ANTENNAPEDIA PROTEIN; HOMEODOMAIN PROTEIN; HYBRID PROTEIN; PEPTIDE; PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; CELL MEMBRANE; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; REVIEW; TARGET CELL; TECHNOLOGY;

ANTENNAPEDIA HOMEODOMAIN PROTEIN; GENE PRODUCTS, TAT; GENE THERAPY; HOMEODOMAIN PROTEINS; HUMANS; NUCLEAR PROTEINS; PROTEINS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; VIRAL STRUCTURAL PROTEINS;

ANIMALIA; HERPES; HUMAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

EID: 0035137639     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301383     Document Type: Review

References (34)

1. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems
2. Cell internalisation of the third helix of antennapedia homeodomain is receptor independent
3. Messenger proteins: Homeoproteins, TAT and others
4. Antennapedia homeobox peptide regulates neural morphogenesis
5. Alpha-2-8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide
6. Neurotrophic activity of the antennapedia homeodomain depends on its specific DNA-binding properties
7. The third helix of the antennapedia homeodomain translocates through biological membranes
8. Intraneuronal delivery of protein-kinase C pseudosubstrate leads to growth cone collapse
9. Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide
10. Transcription factor Hoxa-5 is taken up by cells in culture and conveyed to their nuclei
11. Phosphorylation of the herpex simplex virus type I tegument protein VP22
12. Intercellular trafficking and protein delivery by a herpesvirus structural protein
13. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein VP22
14. Intercellular delivery of functional p53 by the herpesvirus protein VP22
15. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein
16. Cellular uptake of the tat protein from human immunodeficiency virus
17. Endocytosis and targeting of exogenous HIV-1 TAT
18. TAT-mediated delivery of heterologous proteins into cells
19. A truncated HIV-1 TAT protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
20. Delivering information rich drugs-prospect and challenges
21. In vivo protein transduction of a biologically active protein into the mouse
22. kip1 induces cell migration
23. TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point
24. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRB
25. INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1
26. Chemical tags speed delivery into cells. News of the week
27. TAT, the transactivation protein of HIV-1, induces growth of AIDS-Kaposi sarcoma derived cells
28. Human Kaposi's sarcoma cell- mediated tumorigenesis in human immunodeficiency type 1 Tat-expressing transgenic mice
29. Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumour cells to methotrexateiaipeptide prodrugs
30. New advances in the transport of doxorubicin through the blood brain barrier by a peptide vector mediated strategy
31. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes
32. Transient expression of SV40 large T Ag by Cre/LoxP-mediated site-specific deletion in primary human tumour cells
33. Genetically engineered insulin analogs. Diabetes in the new millenium
34. Phase II study of weekly intravenous recombinant humanized anti p185 (HER2) monoclonal antibody in patients with HER2/neu overexpressing metastatic breast cancer